Medical Devices

Florida-based 26Health acquires Optimal Integrative Care, signaling a strategic expansion into Atlanta's competitive healthcare market. What does this mean?

A new report projects massive growth in cardiovascular devices, driven by AI and minimally invasive tech. But can the healthcare system afford this progress?

Western Alliance Bank launches a specialized healthcare banking division led by Jennifer Hwang, aiming to serve a complex and rapidly evolving industry.

As employers grapple with soaring obesity drug costs, a new partnership aims to offer predictable pricing and comprehensive care. Here's how it works.

HeyGears launches a high-performance clear resin, a guided workflow, and a new Amazon store, making pro-level transparent 3D printing more accessible.

Advocates and doctors urge lowering the colorectal cancer screening age to 45 as rates soar in young adults, sparking a debate on policy and resources.

At SXSW, Reckitt Catalyst and Serena Williams unveil a new cohort of U.S. entrepreneurs tackling America's deep-rooted healthcare access crisis.

With domestic production falling and global supplies at risk, experts warn a helium shortage could cripple key U.S. industries from defense to semiconductors.

Italian med-tech firm Esaote unveils its AI-driven Prostate Attention Map, promising a new era of accuracy and confidence in prostate cancer detection.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

A manufacturing flaw in some Omnipod 5 insulin pods has caused serious health issues, prompting a company response and raising questions about device safety.

A legislative movement across 11 states aims to make scalp cooling, a therapy to prevent hair loss during chemo, an insured part of cancer treatment.

Medical tech giant Teleflex goes live with o9's AI planning platform, a strategic move to boost resilience and patient care in a post-pandemic world.

The specialty infusion provider is the first to earn a rigorous new distinction, signaling a major leap forward in patient safety and quality of care.

A plant-based gel that stops severe bleeding in seconds is being showcased to top trauma experts, signaling a major shift in emergency medicine.

Aclarion brings its AI-powered diagnostic tool, NOCISCAN, to a top investor summit, aiming to revolutionize chronic back pain treatment. Can it succeed?

A new clinical trial begins for APAC, a first-in-class drug aiming to prevent amputation and death from severe peripheral artery disease.

After a massive divestiture and balance sheet overhaul, Elutia is all-in on its next-gen biomatrix, NXT-41x, to disrupt the $1.5B breast surgery market.

Industry pioneer Lee Leichter joins EdgeOne Medical, a strategic move to master the complex, high-stakes world of combination product regulation.